COMP <GO>
HLF vs ABBV // FREE CASH FLOW YIELD
Herbalife Ltd. (NYSE) VS. AbbVie Inc. (NYSE) • 15-METRIC TALLY: HLF 5
— ABBV 8
▲ FREE CASH FLOW YIELD LEADER: HLF
LAST: $12.93 (-3.36%) • MKT CAP: $1.36B
fcf-yield
18.66%
LAST: $290.79 (+1.68%) • MKT CAP: $513.86B
fcf-yield
3.47%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (HLF VS. ABBV)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | HLF | ABBV | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 77.90% | 70.20% | +7.70 | HLF | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 34.40% | 29.00% | +5.40 | HLF | /roic <GO> |
| EV/EBITDA & P/E Valuation | 5.4x | 33.3x | -27.90 | HLF | /valuation <GO> |
| Free Cash Flow Yield ACTIVE | 18.66% | 3.47% | +15.19 | HLF | /fcf-yield <GO> |
| Operating Margin | 9.50% | 24.60% | -15.10 | ABBV | /operating-margins <GO> |
| Net Profit Margin | 4.50% | 6.90% | -2.40 | ABBV | /net-margins <GO> |
| Revenue Growth (YoY) | 0.90% | 8.60% | -7.70 | ABBV | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 2.27% | -2.27 | ABBV | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 2.39 | 5.33 | -2.94 | ABBV | /balance-sheet <GO> |
| Piotroski F-Score Quality | 6/9 | 7/9 | -1.00 | ABBV | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 47.5 | 65.1 | -17.58 | ABBV | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 1.15 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 5.5x | 113.1x | -107.60 | HLF | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $1.36B | $513.86B | -$512.50B | ABBV | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | HLF REV | ABBV REV | HLF GROSS % | ABBV GROSS % | HLF FCF | ABBV FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $5.04B | $61.16B | 77.9% | 70.2% | $252.9M | $17.82B |
| FY 2024 | $4.99B | $56.33B | 77.9% | 70.0% | $163.4M | $17.83B |
| FY 2023 | $5.06B | $54.32B | — | — | $357.5M | $20.39B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
HLF // BETA —
ABBV // BETA 1.15